For example, in prostate cancer, the downregulation of ETB results in a higher local concentration of ET-1 which, through the stimulation of ETA receptors, facilitates cancer progression, including proliferation, escape from apoptosis and new bone formation34. This evidence concerns the gene EDNRB and cancer.